Editorial
Where are the at-risk cervical nodes?

https://doi.org/10.1016/S0360-3016(03)01451-2Get rights and content

References (6)

There are more references available in the full text version of this article.

Cited by (7)

  • Heterogeneity in head and neck IMRT target design and clinical practice

    2012, Radiotherapy and Oncology
    Citation Excerpt :

    Historically, definitive H&N radiation has been delivered through opposed lateral shrinking field techniques, broadly covering tumor bed and at-risk nodal regions. Elective nodal coverage has been based on surgical data and patterns of recurrence studies, frequently employing a threshold risk value of 15–25% [28]. Although published guidelines exist to help standardize H&N target delineation, they do not appear to have gained universal adoption; even among established H&N IMRT experts as identified in this report.

  • Role of positron emission tomography in the treatment of occult disease in head-and-neck cancer: A modeling approach

    2011, International Journal of Radiation Oncology Biology Physics
    Citation Excerpt :

    The combination of these two factors rewards an aggressive approach, with a small downside for overtreating patients with false-positive PET results. The current policy for treating occult disease in the lymph nodes is to base the decision to irradiate on the probability of lymph node involvement (16). This probability, obtained from surgical series for the most part, depends on the type and stage of the primary H&N tumor, and patients are categorized as high or low risk.

  • Management of the node-negative neck in early-stage nasopharyngeal carcinoma

    2014, Clinical Insights: Nasopharyngeal Carcinoma: Management Strategies
View all citing articles on Scopus
View full text